Onteis is pioneering a new generation of cancer treatments by harnessing the potential of the tumor microenvironment. Our innovative approach, Cancer Reversion through Normalization, focuses on the anatomical and functional reconstruction of cancerous tissue and its reintegration within the organism. By combining advanced modeling techniques and a deep understanding of the interdependencies between tumors and their surrounding stroma, Onteis is at the forefront of transforming cancer therapy.
| Website | http://onteis.com |
| Employees | 1 (1 on RocketReach) |
| Founded | 2021 |
| Technologies |
HTML
,
Google Analytics
,
G Suite
+5 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Tumor Microenvironment, Cancer Treatment, Cancer Therapies, Oncology, Precision Medicine, Immunotherapy, Cancer Research, Drug Development, Targeted Therapy, Cancer Cells, Clinical Trials, Regenerative Medicine, Biotechnology, Pharmaceutical |
Looking for a particular Onteis employee's phone or email?
Nicolas Andre is the CEO of Onteis.
1 people are employed at Onteis.